These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25669765)

  • 21. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
    Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation.
    van Eerd JE; Boerman OC; Corstens FH; Oyen WJ
    Q J Nucl Med; 2003 Dec; 47(4):246-55. PubMed ID: 14973417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiopharmaceuticals for the study of inflammatory processes: a review.
    Chianelli M; Mather SJ; Martin-Comin J; Signore A
    Nucl Med Commun; 1997 May; 18(5):437-55. PubMed ID: 9194086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques?
    Winkel LC; Groen HC; van Thiel BS; Müller C; van der Steen AF; Wentzel JJ; de Jong M; Van der Heiden K
    Mol Imaging; 2014; 13():. PubMed ID: 24757762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT.
    Ruf J; Steffen I; Mehl S; Rosner C; Denecke T; Pape UF; Plotkin M; Amthauer H
    Nucl Med Commun; 2007 Oct; 28(10):782-8. PubMed ID: 17728608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SPECT/CT.
    Buck AK; Nekolla S; Ziegler S; Beer A; Krause BJ; Herrmann K; Scheidhauer K; Wester HJ; Rummeny EJ; Schwaiger M; Drzezga A
    J Nucl Med; 2008 Aug; 49(8):1305-19. PubMed ID: 18632825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular imaging of plaque vulnerability.
    Tavakoli S; Vashist A; Sadeghi MM
    J Nucl Cardiol; 2014 Dec; 21(6):1112-28; quiz 1129. PubMed ID: 25124827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (68)Ga-radiopharmaceuticals for PET imaging of infection and inflammation.
    Kumar V; Boddeti DK
    Recent Results Cancer Res; 2013; 194():189-219. PubMed ID: 22918761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging T-lymphocytes in inflammatory diseases: a nuclear medicine approach.
    Malviya G; Galli F; Sonni I; Signore A
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):237-57. PubMed ID: 25265246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
    Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC
    Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
    Sodee DB; Sodee AE; Bakale G
    Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New concepts in infection/inflammation imaging.
    Rennen HJ; Corstens FH; Oyen WJ; Boerman OC
    Q J Nucl Med; 2001 Jun; 45(2):167-73. PubMed ID: 11476166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phage display applications for molecular imaging.
    Cai J; Liu Z; Wang F; Li F
    Curr Pharm Biotechnol; 2010 Sep; 11(6):603-9. PubMed ID: 20497117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
    Shapiro B
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting T and B lymphocytes with radiolabelled antibodies for diagnostic and therapeutic applications.
    Malviya G; Galli F; Sonni I; Pacilio M; Signore A
    Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):654-76. PubMed ID: 21221072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical studies of SPECT and PET tracers for NET.
    Brom M; Boerman O; Gotthardt M; Oyen WJ
    PET Clin; 2014 Jan; 9(1):63-9. PubMed ID: 25029935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
    Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
    J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronuclear assessment of patients with epilepsy.
    Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
    Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.